32 results on '"Woodward, Keith"'
Search Results
2. Speed and space: Rates of motion in health and wellbeing
- Author
-
Andrews, Gavin J., Gorman, Richard, Duff, Cameron, and Woodward, Keith
- Published
- 2022
- Full Text
- View/download PDF
3. Endovascular Treatment of Acute Ischemic Stroke With the Penumbra System in Routine Practice: COMPLETE Registry Results
- Author
-
Zaidat, Osama O., Fifi, Johanna T., Nanda, Ashish, Atchie, Benjamin, Woodward, Keith, Doerfler, Arnd, Tomasello, Alejandro, Tekle, Wondwossen, Singh, Inder Paul, Matouk, Charles, Thalwitzer, Jörg, Jargiełło, Tomasz, Skrypnik, Dmitry, Beuing, Oliver, Berge, Jérôme, Katz, Jeffrey M., Biondi, Alessandra, Bonovich, David, Sheth, Sunil A., Yoo, Albert J., and Hassan, Ameer E.
- Published
- 2022
- Full Text
- View/download PDF
4. Situating Flatness
- Author
-
Jones, John Paul, Woodward, Keith, and Marston, Sallie A.
- Published
- 2007
5. Human Geography without Scale
- Author
-
Marston, Sallie A., Jones, John Paul, and Woodward, Keith
- Published
- 2005
6. The speculative geography of Orson Welles
- Author
-
Woodward, Keith
- Published
- 2016
7. Treatment of a ruptured shallow trilobed cerebral aneurysm with the novel saccular endovascular aneurysm lattice (SEAL) device: A case report with one year follow-up.
- Author
-
Pabon, Boris, Torres, Victor, Woodward, Keith, Cardozo, Margarita, Tan, Benedict, Chaubal, Varun, Badruddin, Aamir, Wolfe, Thomas, Pereira, Edgard, Jankowitz, Brian, Costalat, Vincent, Altschul, David, Langerford, Claire A, and Zaidat, Osama O
- Subjects
INTRACRANIAL aneurysms ,ANEURYSMS ,SEALING devices ,SUBARACHNOID hemorrhage ,ANGIOGRAPHY ,CEREBRAL arteries - Abstract
Intrasaccular flow disruption is a viable alternative to other endovascular treatments for saccular or wide-necked bifurcation intracranial aneurysms; however, wide neck aneurysms with irregular shapes or shallow depth may not be amenable to treatment currently available intrasaccular devices. Here, we present the first ever case report of the novel Saccular Endovascular Aneurysm Lattice Embolization System (SEAL™). The versatile utility of the SEAL™ device is demonstrated in a patient with acute subarachnoid hemorrhage (SAH) from a ruptured, complex, left middle cerebral artery (MCA) trilobed shallow wide-necked bifurcation aneurysm. Deployment and implantation of the SEAL device were technically feasible, safe, and conformed well to the irregular shape of the complex, ruptured aneurysm. Immediate total aneurysm occlusion was observed after implantation. Importantly, 1-year angiographic follow-up demonstrated durable, complete occlusion with no safety concerns. The SEAL device is a promising new novel technology which has the potential to treat very shallow aneurysms with limited height and irregular, multilobulated aneurysms. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. One Sinister Hurricane: Simondon and Collaborative Visualization
- Author
-
Woodward, Keith, Jones, John Paul, Vigdor, Linda, Marston, Sallie A., Hawkins, Harriet, and Dixon, Deborah P.
- Published
- 2015
9. Affect, state theory, and the politics of confusion
- Author
-
Woodward, Keith
- Published
- 2014
- Full Text
- View/download PDF
10. March of the kitten herders.
- Author
-
Woodward, Keith
- Published
- 2023
- Full Text
- View/download PDF
11. Of eagles and flies: orientations toward the site
- Author
-
Woodward, Keith, Jones, John Paul, and Marston, Sallie A
- Published
- 2010
12. The Dotter method revisited: early experience with a novel method of rapid internal carotid artery revascularization in the setting of acute ischemic stroke
- Author
-
Woodward, Keith, Wegryn, Scott, Staruk, Carla, and Nyberg, Eric M
- Published
- 2016
- Full Text
- View/download PDF
13. Intravenous alteplase has different effects on the efficacy of aspiration and stent retriever thrombectomy: analysis of the COMPASS trial.
- Author
-
Mokin, Maxim, Waqas, Muhammad, Fifi, Johanna T., de De Leacy, Rea, Fiorella, David, Levy, Elad I., Snyder, Kenneth, Hanel, Ricardo A., Woodward, Keith, Chaudry, Imran, Rai, Ansaar T., Frei, Donald, Delgado Almandoz, Josser E., Kelly, Michael, Arthur, Adam S., Baxter, Blaise W., English, Joey, Linfante, Italo, Fargen, Kyle M., and Turk, Aquilla
- Subjects
ARTERIAL occlusions ,STATISTICS ,INTRAVENOUS therapy ,RESPIRATORY aspiration ,MULTIVARIATE analysis ,CEREBRAL infarction ,SURGICAL stents ,DECISION support systems ,TREATMENT effectiveness ,THROMBECTOMY ,DESCRIPTIVE statistics ,DATA analysis ,DATA analysis software ,TISSUE plasminogen activator - Abstract
Background There is conflicting evidence on the utility of intravenous (IV) alteplase in patients with emergent large vessel occlusion (ELVO) treated with mechanical thrombectomy (MT). Methods This was a post hoc analysis of the COMPASS: a trial of aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion. We compared clinical, procedural and angiographic outcomes of patients with and without prior IV alteplase administration. Results In the COMPASS trial, 235 patients had presented to the hospital within the first 4 hours of stroke symptom onset and were eligible for analysis. On univariate analysis, administration of IV alteplase prior to MT was found to be significantly associated with favorable outcomes (modified Rankin scale (mRS) 0--2 at 3 months; 55.6% vs 40.0% in the MT-only group, P=0.037). However, on multivariate analysis, only baseline (pre-stroke) mRS, admission National Institutes of Health Stroke Scale (NIHSS) score and age were identified as independent predictors of favorable outcomes at 3 months. We found higher final thrombolysis in cerebral infarction (TICI) 2b/3 rates in patients without the use of alteplase prior to the aspiration first approach (100.0% vs 87.9% in IV altepase +aspiration first MT, P=0.03). In the stent retriever first group, final TICI 2b/3 rates were identical in patients with and without IV alteplase administration (87.5% and 87.5%, P=1.0). Conclusions Prior administration of IV alteplase may adversely affect the efficacy of aspiration, but does not seem to influence the stent retriever first approach to MT in patients with anterior circulation ELVO. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Impact of interhospital transfer vs. direct admission on acute ischemic stroke patients: A subset analysis of the COMPLETE registry.
- Author
-
Hassan, Ameer E., Zaidat, Osama O., Nanda, Ashish, Atchie, Benjamin, Woodward, Keith, Doerfler, Arnd, Tomasello, Alejandro, and Fifi, Johanna T.
- Subjects
STROKE patients ,ISCHEMIC stroke ,THROMBECTOMY ,HEALTH facilities ,LENGTH of stay in hospitals - Abstract
Background: Efficacy of thrombectomy treatment in acute ischemic stroke large vessel occlusion (AIS-LVO) patients is time dependent. Direct admission to thrombectomy centers (vs. interhospital transfer) may reduce time to treatment and improve outcomes. In this subset analysis of the COMPLETE registry, we compared outcomes between direct to thrombectomy center (Direct) vs. transfer from another hospital to thrombectomy center (Transfer) in AIS-LVO patients treated with aspiration thrombectomy. Methods: COMPLETE was a prospective, international registry that enrolled patients from July 2018 to October 2019, with a 90-day follow-up period that was completed in January 2020. Imaging findings and safety events were adjudicated by core lab and independent medical reviewers, respectively. Pre-defined primary endpoints included post-procedure angiographic revascularization (mTICI ≥2b), 90-day functional outcome (mRS 0-2), and 90-day all-causemortality. Planned collections of procedural timemetrics and outcomes were used in the present post-hoc analysis to compare outcomes between transfer and direct patient cohorts. Results: Of 650 patients enrolled, 343 were transfer [52.8% female; mean (SD) age, 68.2 (13.9) years], and 307 were direct [55.4% female; 68.5 (14.5) years] admit. Median onset-to-puncture time took longer in the transfer vs. direct cohort (5.65 vs. 3.18 h: 2.33 h difference, respectively; p < 0.001). There was no significant difference in successful revascularization rate, mTICI ≥2b (88.3 and 87.3%), sICH at 24 h (3.8 and 3.9%), median length of hospital stay (7 and 6 days), and 90-day mortality (16.9 and 14.0%) between transfer vs. direct patients, respectively. However, achieving 90-day functional independence was less likely in transfer compared with direct patients (mRS 0-2 was 50.3 vs. 61.7%, p = 0.0056). Conclusions: In the COMPLETE registry, direct to thrombectomy center was associated with significantly shorter onset-to-puncture times, and higher rates of good clinical outcome across different geographies. Additional research should focus on AIS-LVO detection to facilitate direct routing of patients to appropriate treatment centers. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Primary results of the Vesalio NeVa VS for the Treatment of Symptomatic Cerebral Vasospasm following Aneurysm Subarachnoid Hemorrhage (VITAL) Study.
- Author
-
Gupta, Rishi, Woodward, Keith, Fiorella, David, Woo, Henry H., Liebeskind, David, Frei, Donald, Siddiqui, Adnan, de De Leacy, Rea, Hanel, Ricardo, Elijovich, Lucas, and Maud, Alberto
- Subjects
RESEARCH ,CLINICAL trials ,CEREBRAL angiography ,SURGICAL equipment ,CEREBRAL vasospasm ,SUBARACHNOID hemorrhage ,TREATMENT effectiveness ,DESCRIPTIVE statistics ,INTRACRANIAL aneurysms ,PATIENT safety ,LONGITUDINAL method ,DISEASE complications - Abstract
Background Cerebral vasospasm (CV) after aneurysmal subarachnoid hemorrhage (aSAH) is linked to worse neurological outcomes. The NeVa VS is a novel cerebral dilation device based on predicate stent retrievers. We report the results of the Vesalio NeVa VS for the Treatment of Symptomatic Cerebral Vasospasm following aSAH (VITAL) Study. Methods This was a single-arm prospective multicenter trial to assess the safety and probable benefit of the NeVa VS device to treat CV. Patients were screened and treated if they had CV >50% on non-invasive imaging confirmed by cerebral angiography. The vessel diameters were measured before and after treatment by an independent core laboratory. The primary endpoint was ≥50% vessel diameter immediately after treatment with the NeVa VS device. Results Thirty patients with a mean age of 52±11 years and mean Hunt-Hess grade of 3.1±0.9 were enrolled. A total of 74 vessels were treated with an average of 1.3 deployments per vessel (95 deployments total). The mean pre-treatment narrowing of the target vessel (n=74) was 65.6% with reduction of the narrowing to 29.4% after treatment. The primary endpoint was achieved in 64 of 74 vessels (86.5%). In three of 95 total deployments (3.2%), thrombus at the site of deployment was observed during the procedure without apparent neurological sequelae. Conclusions The NeVa VS device appears to be a safe treatment to regain vessel diameter in severely narrowed intracranial arteries secondary to CV associated with aSAH. This treatment offers a new tool that allows for controlled vessel expansion to treat CV. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. AngioSuite: an accurate method to calculate aneurysm volumes and packing densities
- Author
-
Woodward, Keith and Forsberg, David A
- Published
- 2013
- Full Text
- View/download PDF
17. Downsizing Wal-Mart: a reply to Prytherch
- Author
-
Woodward, Keith, Jones, John Paul, III, and Marston, Sallie A.
- Subjects
Globalization -- Analysis ,Space perception -- Analysis ,City planning -- Management ,Company business management ,Geography ,Sociology and social work - Abstract
The article presents a response to David Prytherch's criticism regarding 'Human Geography Without Scale'. Prytherch rejects the idea that scale is an irredeemably chaotic concept and the poorly conceived hierarchies that transcendentalize sociospatial processes.
- Published
- 2008
18. Safety and Long-Term Efficacy Outcomes for Endovascular Treatment of Wide-Neck Bifurcation Aneurysms of the Middle Cerebral Artery: Insights From the SMART Registry.
- Author
-
De Leacy, Reade, Bageac, Devin V., Siddiqui, Neha, Bellon, Richard J., Park, Min S., Schirmer, Clemens M., Woodward, Keith B., Zaidat, Osama O., and Spiotta, Alejandro M.
- Subjects
INTRACRANIAL aneurysms ,ENDOVASCULAR surgery ,CEREBRAL arteries ,TREATMENT effectiveness ,RUPTURED aneurysms ,CEREBRAL revascularization - Abstract
Introduction: Wide-necked middle cerebral artery bifurcation aneurysms pose specific challenges to endovascular management. Surgical clipping remains the standard treatment approach for these aneurysms in many centers. While recent data suggests the endovascular treatment may be comparable, a prospective datapoint has been lacking. Materials and Methods: The Penumbra SMART registry, a prospective, multi-center, single-arm outcomes registry of Penumbra coil-treated aneurysms, was queried for endovascularly treated MCA bifurcation aneurysms with wide necks (dome:neck ratio <2 or neck >4 mm). Safety and efficacy outcomes were summarized for ruptured and unruptured aneurysms, including rupture, complication rate, and 1-year occlusion outcomes. Results: Seventy-two aneurysms across 31 sites were enrolled. Of these, a total of 15 presented as ruptured aneurysms. Serious adverse events were reported in 21 (29.2%) of patients, with 8 (11.1%) attributed to the device/procedure. Immediately postoperatively, 75.0% of cases achieved "adequate" Raymond Roy Class I (40.3%) or II (34.7%) occlusion outcomes. Of the 72 patients treated, 60 (83.3%) underwent follow-up angiography at 1 year, and among these, 95.0% had 1-year occlusion outcomes of Raymond Roy Class I (71.7%) or II (23.3%). A total of 6 aneurysms (10.0%) were required or were planned for retreatment at the last follow-up. Conclusion: This study represents the most significant prospective sample of endovascularly treated wide-neck MCA bifurcation aneurysms conducted to date. It supports the safety and efficacy of endovascular treatment of these aneurysms. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. POSITIVE: Perfusion imaging selection of ischemic stroke patients for endovascular therapy.
- Author
-
Mocco, J., Siddiqui, Adnan H., Fiorella, David, Alexander, Michael J., Arthur, Adam S., Baxter, Blaise W., Budzik, Ronald F., Froehler, Michael T., Hanel, Ricardo A., Lena, Jonathan, Persaud, Steven, Puri, Ajit S., Rai, Ansaar T., Wintermark, Max, Woodward, Keith, Zhang, Xiangnan, and Turk, Aquilla
- Subjects
RESEARCH ,CONFIDENCE intervals ,ISCHEMIC stroke ,PATIENT selection ,MEDICAL cooperation ,MAGNETIC resonance imaging ,FISHER exact test ,RADIONUCLIDE imaging ,RANDOMIZED controlled trials ,T-test (Statistics) ,STROKE patients ,DESCRIPTIVE statistics ,ENDOVASCULAR surgery ,DATA analysis software ,ODDS ratio ,PERFUSION ,LONGITUDINAL method ,CEREBRAL ischemia - Abstract
Background The PerfusiOn imaging Selection of Ischemic sTroke patIents for endoVascular thErapy (POSITIVE) trial was designed to evaluate functional outcome in patients with emergent large vessel occlusion (ELVO) presenting within 0--12 hours with pre- specified bifurcated arms of early and late window presentation, who were selected for endovascular thrombectomy with non- vendor specific commercially available perfusion imaging software. Recent trials demonstrating the benefit of thrombectomy up to 16-- 24 hours following ELVO removed equipoise to randomize late window ELVO patients and therefore the trial was halted. Methods Up to 200 patients were to be enrolled in this FDA- cleared, prospective, randomized, multicenter international trial to compare thrombectomy and best medical management in patients with ELVO ineligible for or refractory to treatment with IV tissue plasminogen activator (IV- tPA) selected with perfusion imaging and presenting within 0--12 hours of last seen normal. The primary outcome was 90- day clinical outcome as measured by the raw modified Rankin Scale (mRS) with scores 5 and 6 collapsed (mRS shift analysis). Results The POSITIVE trial suspended enrollment with the release of results from the DAWN trial and was stopped after the release of the DEFUSE 3 trial results. Thirty- three patients were enrolled (21 for medical management and 12 for thrombectomy). Twelve of the 33 patients were enrolled in the 6--12 hour cohort. Despite the early cessation, the primary outcome demonstrated statistically significant superior clinical outcomes for patients treated with thrombectomy (P=0.0060). The overall proportion of patients achieving an mRS score of 0--2 was 75% in the thrombectomy cohort and 43% in the medical management cohort (OR 4.00, 95% CI 0.84 to 19.2). Conclusion POSITIVE supports the already established practice of delayed thrombectomy for appropriately selected patients presenting within 0--12 hours selected by perfusion imaging from any vendor. The results of the POSITIVE trial are consistent with other thrombectomy trials. The statistically significant effect on functional improvement, despite the small number of patients, reinforces the robust benefits of thrombectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Clot perviousness is associated with first pass success of aspiration thrombectomy in the COMPASS trial.
- Author
-
Mokin, Maxim, Waqas, Muhammad, Fifi, Johanna, de De Leacy, Rea, Fiorella, David, Levy, Elad I., Snyder, Kenneth, Hanel, Ricardo, Woodward, Keith, Chaudry, Imran, Rai, Ansaar T., Frei, Donald, Delgado Almandoz, Josser E., Kelly, Michael, Arthur, Adam S., Baxter, Blaise W., English, Joey, Linfante, Italo, Fargen, Kyle M., and Turk, Aquilla
- Subjects
THROMBOSIS risk factors ,STATISTICS ,CONFIDENCE intervals ,CEREBRAL infarction ,MULTIVARIATE analysis ,VEIN surgery ,TREATMENT effectiveness ,THROMBECTOMY ,DESCRIPTIVE statistics ,ANGIOGRAPHY ,DATA analysis ,ODDS ratio - Abstract
Background Clot density (Hounsfield units, HU) and perviousness (post- contrast increase in the HU of clot) are thought to be associated with clot composition. We evaluate whether these imaging characteristics were associated with angiographic outcomes of aspiration and stent retriever thrombectomy in COMPASS: a trial of aspiration thrombectomy versus stent retriever thrombectomy as first- line approach for large vessel occlusion. Methods Clot density and perviousness were measured by two independent operators who were blind to all the final angiographic and clinical outcomes. The association of clot density and perviousness with the Thrombolysis In Cerebral Infarction (TICI) scale after first pass was assessed using univariate and multivariate analysis. Results Among all patients enrolled in COMPASS, 165 were eligible for the post- hoc analysis (81 patients in the aspiration first and 84 in the stent retriever first groups). Overall mean perviousness of clot was significantly higher in patient with mTICI 2b-3 after first pass (28.6±22.9 vs 20.3±19.2, p=0.017). Mean perviousness among patients who achieved TICI 2c/3 versus TICI 2b versus TICI 0- 2a in the aspiration first group varied significantly (32.6±26.1, 35.3±24.4, and 17.7±13.1, p=0.013). The association of perviousness with first pass success was not significant in the stent retriever group. Using multivariate analysis, high perviousness (defined as cut- off >27.6) was an independent predictor of TICI 2b-3 (OR 3.82, 95% CI 1.10 to 13.19; p=0.034). Conclusions Clot perviousness is associated with first pass angiographic success in patients treated with the aspiration first approach for thrombectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. An international multicenter retrospective study to survey the landscape of thrombectomy in the treatment of anterior circulation acute ischemic stroke: outcomes with respect to age.
- Author
-
Martini, Michael, Mocco, J., Turk, Aquilla, Siddiqui, Adnan H., Fiorella, David, Hanel, Ricardo, Woodward, Keith, Rai, Ansaar, Frei, Don, Delgado Almandoz, Josser E., Kelly, Michael E., Peeling, Lissa, Arthur, Adam S., Baxter, Blaise, English, Joey, Linfante, Italo, and De Leacy, Reade
- Subjects
AGE distribution ,MEDICAL cooperation ,RESEARCH ,STROKE ,THROMBOSIS ,VEIN surgery ,LOGISTIC regression analysis ,TREATMENT effectiveness ,RETROSPECTIVE studies ,ACUTE diseases ,REVASCULARIZATION (Surgery) ,DESCRIPTIVE statistics - Abstract
Background Thrombectomy is an efficacious treatment for acute ischemic stroke (AIS). However, relatively few studies to date have specifically examined the impact and clinical implications of age on outcomes for thrombectomy in anterior AIS. Objective To provide a snapshot of patient metrics and outcomes with respect to age following thrombectomy for anterior AIS to supplement the current body of data for predictors of clinical outcomes in a real-world setting. Methods Data were collected for 20 consecutive patients with AIS treated with thrombectomy at 15 highvolume stroke centers across North America between 2015 and 2016. Patients with anterior occlusions were dichotomized based on whether they were older or younger than 80 years. Ordinal logistic regression analyzed how clinical variables impacted disability using 90-day modified Rankin Scale (mRS) scores. results Adequate revascularization (TICI ≥2B) was achieved in 92.3% of patients aged <80 years with an average 1.7±0.1 passes taken with the primary technique and in 88.0% of patients aged ≥80 years with an average 1.7±0.2 passes. Despite similar baseline characteristics, mRS scores were significantly higher in older patients postoperatively and at 90 days after intervention. Age was a significant predictor of 90-day mRS across the study population. Conclusion This analysis affirms age is a significant determinant of 90-day mRS scores following thrombectomy for large vessel anterior AIS. Further investigation into risks faced by elderly patients during thrombectomy may provide actionable information to help refine patient selection and improve outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. State reason and state affect
- Author
-
Woodward, Keith
- Published
- 2016
- Full Text
- View/download PDF
23. 'Real-world' comparison of first-line direct aspiration and stent retriever mechanical thrombectomy for the treatment of acute ischemic stroke in the anterior circulation: a multicenter international retrospective study.
- Author
-
Martini, Michael, Mocco, J., Turk, Aquilla, Siddiqui, Adnan H., Fiorella, David, Hanel, Ricardo A., Woodward, Keith, Rai, Ansaar, Frei, Don, Almandoz, Josser E. Delgado, Kelly, Michael E., Peeling, Lissa, Arthur, Adam S., Baxter, Blaise, English, Joey, Linfante, Italo, and De Leacy, Reaed
- Subjects
MEDICAL cooperation ,RESEARCH ,STROKE ,THROMBOSIS ,VEIN surgery ,LOGISTIC regression analysis ,TREATMENT effectiveness ,RETROSPECTIVE studies ,REVASCULARIZATION (Surgery) ,STROKE patients ,DESCRIPTIVE statistics - Abstract
Background Thrombectomy for anterior large vessel occlusion less than 24 hours since last known well is now standard of care. Certain aspects of clinical trials may limit generalizability to 'real-world' practice. Objective To compare revascularization rates and outcomes for direct aspiration (ADAPT) and stent retriever thrombectomy following anterior acute ischemic stroke (AIS) in a real-life setting. Methods Data from the most recent 20 consecutive patients with AIS treated with mechanical thrombectomy between 2015 and 2016 were collected from 15 high-volume stroke centers across North America for a total of 300 cases. Patients with proximal anterior large vessel occlusions were dichotomized by primary treatment technique. Ordinal logistic regression assessed the effects of clinical variables on patient disability using 90-day modified Rankin Scale (mRS) scores. Results Adequate revascularization (Thrombolysis in Cerebral Infarction ≥2b) was ultimately achieved in 91.2% of first-line direct aspiration (ADAPT) cases with an average of 1.9±1.9 passes and in 87.5% of stent retriever cases with an average of 1.7±1.0 passes. Time from groin puncture to revascularization was shorter for ADAPT cases. The mean 90-day mRS score for both groups was 3.0±2.4. Number of passes using primary technique, and postintervention intracranial hemorrhage, were significant predictors of 90-day mRS scores after ADAPT, while age and preprocedure mRS score were predictive of outcomes following first-line stent retriever. Conclusions Our data show similar adequate revascularization rates and 90-day functional outcomes for first-line direct aspiration and stent retrievers for anterior large vessel occlusion in a real-world setting. These results support the findings of other prospective trials evaluating the two techniques. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
24. Touching Like a State.
- Author
-
Woodward, Keith and Bruzzone, Mario
- Subjects
- *
PROTEST movements , *TOUCH , *POLICE , *ACTIVISTS , *INDIVIDUAL & state , *VIOLENCE , *VIOLENCE & society - Abstract
This paper offers a theorization of how the state touches. Through an analysis of the extensive 2011 protests over Wisconsin Senate Bill 11, we interrogate the relatively non-violent interactions between police and protesters during the 17-day occupation of the Wisconsin State Capitol building. On display there were diverse police deployments of 'soft' force and haptic touching, technologies that enabled officers to subtly affect the movements and relations of protester crowds without resorting to familiar coercion- and consent-based politics. We offer a pair of concepts, cathexis and l'esprit de l'escalier, to diagram how statist touches were mobilized to catch individuals unawares and momentarily co-opt their bodily affects. These modes of control suggest much greater savvy regarding touch, force, and affect than is often granted in representations of the state apparatus. In light of this, we close with a reflection on the changing tactical grounds for struggle. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
25. The politics of autonomous space.
- Author
-
Woodward, Keith, Jones, John Paul, and Marston, Sallie A.
- Subjects
- *
ONTOLOGY , *POLITICAL autonomy , *AUTONOMY & independence movements , *PRACTICAL politics , *POLITICAL knowledge , *SUBJECTIVITY ,SOCIAL aspects - Abstract
This paper offers a further exploration of ‘flat ontology’, an account of the world that takes the immanence of localized, material process to be fundamentally different from and ontologically prior to transcendent, structured, and formal treatments of space. Our previous work in this area aimed at developing the concept of the site – via site ontology– as an ‘event-space’ that describes the differential contours and pressures of aggregating and dispersing bodies. This paper’s contribution lies in considering how politics and political potentials are specified by such event-spaces. In geography and other fields, politics has nearly always been thought to proceed from and to exist for subjects, regardless of how they get theorized. Here we explore how the site might initiate politics that neither presuppose nor undergird individual subject positionalities or mass identitarian categories. We argue that subjectivity – widely understood to be the motive force in organizing politics – is often ‘suspended’ where bodies encounter or get enlisted in the unanticipated connections and relations that site ontology describes. Thus, our account understands the site as autonomous with respect to the subject in two crucial ways. The site is: (1) organizationally autonomous: its rules emerge from its specific, localized relations and this material immanence makes the site the legislator of its own assembly; and (2) politically autonomous: that is, not conditioned by the political schemata of subjectivity per se, even though sites diversely and differently enlist and reshuffle bodies that often attend to, direct, participate in, and inhabit subjective politics. [ABSTRACT FROM PUBLISHER]
- Published
- 2012
- Full Text
- View/download PDF
26. On the other hand ... dialectics.
- Author
-
Dixon, Deborah P., Woodward, Keith, and Jones III, John Paul
- Subjects
- *
DIALECTIC , *MODALITY (Theory of knowledge) , *RATIONALISM , *THOUGHT & thinking , *HEGELIANISM , *HISTORY - Abstract
The author reflects on the concept and nature of dialectics. Accordingly, dialectic has expresses classical and modern analytical thinking with regards to the relationality which is conceptualized between people, ideas, and the world. He remarks that the existence of scientific rationalism involved on a sustained critique of the dialectic. The author also notes on the poststructionalist theorist which was related to Hegelian dialectic and compared to the forms of distribution and debate.
- Published
- 2008
- Full Text
- View/download PDF
27. Flattening Ontologies of Globalization: The Nollywood Case.
- Author
-
Marston, SallieA., Woodward, Keith, and Jones, John Paul
- Subjects
- *
MULTICULTURALISM , *CULTURE & globalization , *ONTOLOGY , *CULTURE conflict , *HEGEMONY - Abstract
In this article we offer some criticisms regarding the spatial ontologies that have underwritten theories of globalization. We evaluate different approaches to understanding their workings, each of which must grapple with the problem of connecting the local and the global, and contrast these to that of our recent work aimed at elaborating a 'flat ontology'. The central feature of this alternative ontology is the site: a material localization characterized by differential relations through which one site is connected to other sites, out of which emerges a social space that can be understood to extend, however unevenly and temporarily, across distant places. Yet, in light of its focus on practices - on situated sayings and doings - our ontology must refuse the spatial imaginaries that underpin nearly all discussions of globalization. To illustrate our position we examine the practices of popular filmmaking within Lagos, Nigeria (Nollywood). This site is an entry point for comprehending and enlarging upon the political implications of our ontology - one that is meant not only to rethink globalization but to unsettle the abstractions that enable its expanding hegemony. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
28. Editors' Introduction.
- Author
-
Mayer, Danny and Woodward, Keith
- Subjects
- *
GLOBALIZATION , *INTERNATIONAL relations - Abstract
Introduces a series of articles on the topic of globalization.
- Published
- 2004
29. Global Wars and Writing Warrior Culture: disClosure interviews Anthony Swofford.
- Author
-
Froula, Anna, Mayer, Danny, Vincent, Jonathan, and Woodward, Keith
- Subjects
WAR ,GLOBALIZATION ,NATIONAL character ,INTERNATIONAL relations ,MILITARY personnel - Abstract
Interviews English professor Anthony Swofford about his views on U.S. wars in the Gulf in the contexts of the emergence of globalization, the transformation of nations and national identities, and the changing social and political characteristics of the soldier. Speculations about the possible changing contexts for the Jarhead; Legitimacy of military commanders to enter into the democratic race; Desire of the U.S. for war due to post-war alienation.
- Published
- 2004
30. Globalization in 25 Words or Less.
- Author
-
Woodward, Keith and Mayer, Danny
- Subjects
- *
GLOBALIZATION , *COLLEGE students - Abstract
Introduces a series of articles on the definitions of globalization according to undergraduate students from around the world.
- Published
- 2004
31. The balloon occlusion sheath for stroke (BOSS) balloon guide catheter for stroke intervention: Safety and technical success.
- Author
-
Cuoco, Joshua A, Entwistle, John J, Siddiq, Farhan, Puri, Ajit S, Woodward, Keith, Hanel, Ricardo A, Ansari, Sameer A, Frei, Donald, and Patel, Biraj M
- Abstract
We describe the first-in-human experience using the Balloon Occlusion Stroke Sheath (BOSSTM) balloon-guide catheter to perform stroke thrombectomy in 50 consecutive patients enrolled in the Flow Arrest Safety and Technical success with balloon-guide catheters trial. This aspiration system includes a novel 9.4F balloon-guide catheter conduit for the insertion and guidance of catheters with a balloon providing temporary flow arrest.The Flow Arrest Safety and Technical success with balloon-guide catheter trial is a single-arm, prospective, multi-center, non-randomized, observational registry evaluating the use of the market-released BOSSTM balloon-guide catheter in adult patients diagnosed with an acute ischemic stroke attributable to large vessel occlusion. The purpose of the current trial was to assess the safety and technical success associated with the use of the BOSSTM balloon-guide catheter.Fifty patients met inclusion criteria with a mean baseline National Institutes of Health Stroke Scale (NIHSS) of 16. Treatment devices, including aspiration and stent retriever devices, were used in a total of 88 passes. The BOSSTM balloon-guide catheter was compatible with all stroke thrombectomy treatment devices used in 98% (49/50) of procedures. Balloon inflation and flow arrest were achieved in 100% (50/50) and 98% (49/50) of cases, respectively. Balloon deflation and retraction were observed in 100% (50/50) of cases. Successful reperfusion (modified thrombolysis in cerebral infarction score > 2b) was achieved in 100% of cases with single-pass reperfusion achieved in 62% (31/50) of cases.The BOSSTM balloon-guide catheter is a safe and technically effective adjunctive device for mechanical thrombectomy of acute ischemic stroke due to large vessel occlusion. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Primary results from the CLEAR study of a novel stent retriever with drop zone technology.
- Author
-
Yoo AJ, Geyik S, Froehler MT, Maurer CJ, Kass-Hout T, Zaidat OO, Nogueira RG, Hanel RA, Pierot L, Spelle L, Lopes D, Hassan A, Širvinskas A, Lin E, Ribo M, Blasco J, Taqi MA, Badruddin A, Siddiqui AH, Miller TR, Hussain SM, Haussen DC, Woodward K, Groden C, Consoli A, Chaudry MI, Ramsey C, Maud A, Bentley J, Bajrami A, Sahnoun M, Fiehler J, and Gupta R
- Abstract
Background: Challenges to revascularization of large vessel occlusions (LVOs) persist. Current stent retrievers have limited effectiveness for removing organized thrombi. The NeVa device is a novel stent retriever designed to capture organized thrombi within the scaffold during retrieval., Objective: To evaluate the safety and effectiveness of revascularization of acute LVOs with the NeVa device., Methods: Prospective, international, multicenter, single-arm, Investigational Device Exemption study to evaluate the performance of the NeVa device in recanalizing LVOs including internal carotid artery, M1/M2 middle cerebral artery, and vertebrobasilar arteries, within 8 hours of onset. Primary endpoint was rate of expanded Treatment in Cerebral Ischemia (eTICI) score 2b-3 within 3 NeVa passes, tested for non-inferiority against a performance goal of 72% with a -10% margin. Additional endpoints included first pass success and 90-day modified Rankin Scale (mRS) score 0-2. Primary composite safety endpoint was 90-day mortality and/or 24-hour symptomatic intracranial hemorrhage (sICH)., Results: From April 2021 to April 2022, 139 subjects were enrolled at 25 centers. Median National Institutes of Health Stroke Scale (NIHSS) score was 16 (IQR 12-20). In the primary analysis population (n=107), eTICI 2b-3 within 3 NeVa passes occurred in 90.7% (97/107; non-inferiority P<0.0001; post hoc superiority P<0.0001). First pass eTICI 2b-3 was observed in 73.8% (79/107), with first pass eTICI 2b67-3 in 69.2% (74/107) and eTICI 2c-3 in 48.6% (52/107). Median number of passes was 1 (IQR 1-2). Final eTICI 2b-3 rate was 99.1% (106/107); final eTICI 2b67-3 rate was 91.6% (98/107); final eTICI 2c-3 rate was 72.9% (78/107). Good outcome (90-day mRS score 0-2) was seen in 65.1% (69/106). Mortality was 9.4% (13/138) with sICH in 5.0% (7/139)., Conclusions: The NeVa device is highly effective and safe for revascularization of LVO strokes and demonstrates superior first pass success compared with a predicate performance goal., Trial Registration Number: NCT04514562., Competing Interests: Competing interests: AJY: consultant: Penumbra, Cerenovus, Vesalio, Zoll Circulation, Philips Neurovascular; individual stocks/stock options: Nicolab; ownership interest: Insera Therapeutics, Galaxy Therapeutics; research funding (principal investigator (PI) or named investigator): Medtronic, Cerenovus, Penumbra, Stryker, Genentech. LS: consultant: Balt, Medtronic, Microvention, Stryker; research funding (PI or named investigator): Philips. AH: consultant: Medtronic, Microvention, Stryker, Penumbra, Cerenovus, Genentech, GE Healthcare, Scientia, Balt, Viz.ai, Insera therapeutics, Proximie, NeuroVasc, NovaSignal, Vesalio, Rapid Medical, Imperative Care. AS: consultant: Microvention, Stryker, Vesalio. AHS: consultant: Amnis Therapeutics, Apellis Pharmaceuticals, Inc., Boston Scientific, Canon Medical Systems USA, Inc., Cardinal Health 200, LLC, Cerebrotech Medical Systems, Inc., Cerenovus, Cerevatech Medical, Inc; inidividual stocks/stock options: Adona Medical, Inc., Amnis Therapeutics, Bend IT Technologies, Ltd., BlinkTBI, Inc, Borvo Medical, Inc., Cerebrotech Medical Systems, Inc., Cerevatech Medical, Inc., Cognition Medical, Collavidence, I; other; Cerenovus EXCELLENT and ARISE II Trial; Medtronic SWIFT PRIME, VANTAGE, EMBOLISE and SWIFT DIRECT Trials; MicroVention FRED Trial; CONFIDENCE Study; MUSC POSITIVE Trial; Penumbra 3D Separator Trial, Research Funding (PI or named investigator); co-investigator for NIH - 1R01EB030092-01, Project Title: High speed angiography at 1000 frames per second; Mentor for Brain Aneurysm Foundation Carol W. Harvey Chair of Research, Sharon Epperson Chai. SG: Consultant; Stryker, Microvention, Medtronic. TRM: Advisor; Carpl AI. MTF: advisor; Cerenovus; research funding (PI or named investigator): Medtronic Neurovascular; researcher: Stryker Neurovascular, Cerenovus, Rapid Medical. DCH: consultant; Stryker Neurovascular, Cerenovus, Chiesi USA, Brainomix, Poseydon Medical; individual stocks/stock options: VizAI and Motif; other: Jacobs Institute/Medtronic, Vesalio., Frontiers in Neurology. MIC: advisor: Celt/Vasorum; consultant: Microvention, Medtronic, Imperative Care, Q'Apel; individual stocks/stock options: Imperative Care, Celt/Vasorum, Synchron, Endostream, Cerebrotech, Q'Apel, RIST, Three Rivers Medical, Neuolutions, Radical Medical, Tulavi, viseon, VMT, Vastrax, Serenity Medical. MF: consultant: Cerenovus, Balt, Jacobs Institute, Kai Medical, Oculus; research funding (PI or named investigator): Vesalio, Genentech, Siemens. MS: consultant: Vesalio., (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.